$ACHN Company News 10 Nasdaq stocks with retur
Post# of 144499
Posted On: 10/01/2014 9:35:18 AM
$ACHN Company News
10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 12:56 p.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 5:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Momentum Stocks Showing Weakness 4:33 p.m. Sept. 15, 2014 - benzinga.com
Midday Losers From September 15 - Tesla Motors Inc, Digital Ally, Inc. And More 11:56 a.m. Sept. 15, 2014 - benzinga.com
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks 10:59 a.m. Sept. 15, 2014 - 247WallSt.com
Morning Market Losers 8:48 a.m. Sept. 15, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Losers 8:45 a.m. Sept. 12, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:06 a.m. Sept. 12, 2014 - benzinga.com
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Sept. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts 7:47 p.m. Sept. 11, 2014 - TheStreet.com
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape 10:58 a.m. Sept. 10, 2014 - Zacks.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"
7:00 a.m. Aug. 15, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF
If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc. 7:00 a.m. June 13, 2014 - PR Newswire - PRF
10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 12:56 p.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 5:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Momentum Stocks Showing Weakness 4:33 p.m. Sept. 15, 2014 - benzinga.com
Midday Losers From September 15 - Tesla Motors Inc, Digital Ally, Inc. And More 11:56 a.m. Sept. 15, 2014 - benzinga.com
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks 10:59 a.m. Sept. 15, 2014 - 247WallSt.com
Morning Market Losers 8:48 a.m. Sept. 15, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Losers 8:45 a.m. Sept. 12, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:06 a.m. Sept. 12, 2014 - benzinga.com
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Sept. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts 7:47 p.m. Sept. 11, 2014 - TheStreet.com
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape 10:58 a.m. Sept. 10, 2014 - Zacks.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"
7:00 a.m. Aug. 15, 2014 - GlobeNewswire Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF
If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc. 7:00 a.m. June 13, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼